PILOT AND FEASIBILITY PROGRAM

试点和可行性（P&F）计划自1978年成立以来已资助了85个项目（包括2006年）。 该计划非常有价值和有效，为支持糖尿病相关疾病提供了资金。 项目该计划的目标是支持新的研究人员（谁）的小型研究项目 很少或没有独立的研究支持）或已建立的研究人员转向糖尿病 第一次研究。绝大多数提案属于前一类。三个新项目 通常每年都会启动。经过全校范围内的建议征求，四个人（两个 两个机构内部和两个机构外部）审查每一笔赠款。对该提案的批评由以下因素评估： P&F审查委员会（相当于NIH的研究部门），每个提案都有优先级 得分然后将提案和优先级分数提交给DRTC执行委员会（相当于 向NIH理事会）申请资助。第二年的研究支持是在以下情况下颁发的 如果在第一年完成了令人满意的工作， 临时的 这个项目的成功率，无论是通过参与调查的人数来衡量， 糖尿病研究，或谁转换他们的P&F到一个国家授予，同行评审的赠款，是高（75%的 1996-2000年资助的赠款）。此外，该计划还为各种申请提供资金 机构内的部门。例如，来自医学系、分子生物学系、 生理学和生物物理学，生物化学，生物医学工程，麻醉，儿科，细胞和 发育生物学、化学、护理学和病理学在过去五年中得到了资助。P&F 该计划还为DRTC在范德比尔特科学界提供了可见度， 科学界更了解DRTC，其研究工作及其核心设施。的重要性 VUMC领导层的决定强调了DRTC P&F计划的有效性， 在下一个融资周期为该计划提供额外资金（10万美元）。

The Pilot and Feasibility (P&F) program has funded 85 projects (including 2006) since it inception in 1978. This program has been extremely valuable and effective by providing funds for the support of diabetesrelated projects. The goal of the program is to support small research projects by new investigators (who have little or no independent research support) or established investigators who are turning to diabetes research for the first time. The vast majority of the proposals are in the former category. Three new projects are normally initiated each year. After a university-wide solicitation of proposals, four individuals (two internal and two external to the institution) review each grant. The critiques of the proposal are evaluated by the P&F Review Committee (equivalent to an NIH study section), and each proposal is assigned a priority score. The proposals and priority scores are then presented to the DRTC Executive Committee (equivalent to the NIH Council) for a funding decision. Support for a second year of research is awarded when satisfactory work is completed in year one and if support for the projects has not been obtained in the interim. The success rate of this program, measured either by the number of investigators who remain involved in diabetes research, or who convert their P&F into a nationally awarded, peer-reviewed grant, is high (75% of grants funded from 1996-2000). In addition, this program funds applications from a wide variety of departments within the institution. For example, faculty members from Departments of Medicine, Molecular Physiology and Biophysics, Biochemistry, Biomedical Engineering, Anesthesia, Pediatrics, Cell and Developmental Biology, Chemistry, Nursing, and Pathology were funded over the past five years. The P&F program also provides visibility for the DRTC within the Vanderbilt scientific community and thus makes the scientific community more aware of the DRTC, its research efforts, and its core facilities. The importance and effectiveness of the DRTC P&F program is underscored by the decision of the VUMC leadership to provide additional funds ($100K) for this program in the next funding cycle.